- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Breast cancer
- Meeting Date: July 2020
- Public Summary Document (PSD) July 2020 PBAC Meeting - (PDF 1827KB)
- Public Summary Document (PSD) July 2020 PBAC Meeting - (Word 468KB)
Ribociclib – July 2020
Ribociclib: Tablet 200 mg; Kisqali®
Last updated
13 November 2020